港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

醫美概念股

617.392

+1.4820.24%

漲家數：4

跌家數：6

平家數：3

市盈率：- -

高：633.963

開：614.939

低：614.939

收：615.910

資料載入中...

瑞麗醫美盤中異動快速拉昇6.73%報0.111港元

復星醫藥再出手！頻頻減持山河藥輔累計套現逾1.2億元

读创客户端

山河藥輔：股東擬減持不超過3%公司股份

中国财富网

復鋭醫療科技盤中異動快速跳水5.26%報3.600港元

山河藥輔：股東復星醫藥因經營需要擬減持不超過3%公司股份

山河藥輔(300452.SZ)股東復星醫藥擬減持不超3%股份

【山河藥輔：股東復星醫藥擬減持不超過3%公司股份】山河藥輔公告，股東上海復星醫藥產業發展有限公司因經營需要，計劃以集中競價和大宗交易方式合計減持公司股份不超過697.8萬股，即不超過公司總股本的3%。

【上海市工商聯生物醫藥商會揭牌，陳啓宇當選首任會長】2月22日，上海市工商聯生物醫藥商會第一屆一次會員會議暨生物醫藥發展大會在閔行區虹橋西郊莊園麗笙大酒店舉行。上海市工商聯生物醫藥商會正式揭牌，辦公落地閔行區，上海復星醫藥股份有限公司非執行董事陳啓宇當選首任會長。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1593/news?page=9"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"醫美概念股","latestPrice":617.3917,"timestamp":1741579196667,"preClose":615.91016,"halted":0,"volume":56964274,"delay":0,"changeRate":0.002405,"change":1.481567,"pbRate":1.190795,"amount":423752459,"amplitude":0.030888,"prevYearClose":571.87146,"fiveDayClose":604.125,"twentyDayClose":578.349,"turnoverRate":0.002844,"marketCap":111104330656,"floatMarketCap":73448326880,"peRate":21.56404},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":633.96344,"amplitude":0.030888,"preClose":615.91016,"low":614.9391,"pbRate":"1.190795","latestPrice":617.3917,"volume":56964274,"delay":0,"open":614.9391,"prevYearClose":571.87146,"prevWeekClose":615.91,"prevMonthClose":612.07,"prevQuarterClose":571.871,"fiveDayClose":604.125,"twentyDayClose":578.349,"sixtyDayClose":582.226,"secType":"PLATE","market":"HK","turnoverRate":0.002844,"peRate":21.56404,"marketCap":111104330656,"floatMarketCap":73448326880,"timestamp":1741579196667,"nameCN":"醫美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":4,"down":6,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:16,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2513147798","title":"瑞麗醫美盤中異動 快速拉昇6.73%報0.111港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513147798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513147798?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 09:41","pubTimestamp":1740361306,"startTime":"0","endTime":"0","summary":"2025年02月24日早盘09时41分，瑞丽医美股票出现波动，股价大幅上涨6.73%。截至发稿，该股报0.111港元/股，成交量10万股，换手率0.02%，振幅6.73%。资金方面，该股资金流入8320港元，流出0港元。瑞丽医美股票所在的医疗及医学美容服务行业中，整体涨幅为0.05%。其相关个股中，瑞丽医美、脑动极光-B、固生堂涨幅较大，振幅较大的相关个股有健康之路、讯飞医疗科技、瑞丽医美，振幅分别为16.00%、10.65%、6.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022409414698902e65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022409414698902e65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1209","BK1593","02135"],"gpt_icon":0},{"id":"2513798794","title":"復星醫藥再出手！頻頻減持山河藥輔 累計套現逾1.2億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513798794","media":"读创客户端","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513798794?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 09:41","pubTimestamp":1740361299,"startTime":"0","endTime":"0","summary":"山河药辅表示，复星医药拟减持时间为2025年3月18日至6月15日，拟减持价格根据减持时市场价格及相关规定确定，不低于发行价。目前，复星医药持有山河药辅2392.81万股，占该公司总股本比例为10.20%，为其第二大股东。近年来，复星医药多次出手减持。以此计算，复星医药套现约2770.27万元。另据iFind数据统计，2018年—2020年，复星医药7次减持山河药辅，累计套现约9800万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224095519962dd60c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224095519962dd60c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02196","BK1515","BK1593"],"gpt_icon":0},{"id":"2513601267","title":"山河藥輔：股東擬減持不超過3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2513601267","media":"中国财富网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513601267?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 09:33","pubTimestamp":1740360832,"startTime":"0","endTime":"0","summary":"根据公告，复星医药目前持有山河药辅股份23,928,059股，占公司总股本的10.20%。此次减持计划涉及不超过6,978,000股，占公司总股本的3%。复星医药表示，此次减持的主要原因是根据其自身经营需要，获取投资收益。公告还提到，复星医药在山河药辅首次公开发行时的股份锁定和减持承诺已履行完毕，未出现违反承诺的行为。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224094444a2513e6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224094444a2513e6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1593","BK1515","BK1191"],"gpt_icon":0},{"id":"2513760811","title":"復鋭醫療科技盤中異動 快速跳水5.26%報3.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513760811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513760811?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 09:30","pubTimestamp":1740360634,"startTime":"0","endTime":"0","summary":"2025年02月24日早盘09时30分，复锐医疗科技股票出现异动，股价急速跳水5.26%。截至发稿，该股报3.600港元/股，成交量12.28万股，换手率0.03%，振幅5.00%。资金方面，该股资金流入8904港元，流出40.3096万港元。复锐医疗科技股票所在的医疗设备及用品行业中，整体涨幅为0.05%。其相关个股中，先瑞达医疗-B、心通医疗-B、微泰医疗-B涨幅较大，振幅较大的相关个股有复锐医疗科技、堃博医疗-B、爱康医疗，振幅分别为5.00%、3.66%、3.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224093034989029f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224093034989029f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1585","BK1100","01696"],"gpt_icon":0},{"id":"2513759975","title":"山河藥輔：股東復星醫藥因經營需要擬減持不超過3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2513759975","media":"观点网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513759975?lang=zh_tw&edition=fundamental","pubTime":"2025-02-23 23:11","pubTimestamp":1740323511,"startTime":"0","endTime":"0","summary":"观点网讯：山河药辅2月23日公告，股东上海复星医药产业发展有限公司因经营需要，计划以集中竞价和大宗交易方式合计减持公司股份不超过697.8万股，即不超过公司总股本的3%。 山河药辅表示，公司生产经营情况正常。本次拟减持股份的股东不属于公司的控股股东或实际控制人，本次股份减持不会导致公司控制权发生变更，不会对公司治理结构、股权结构及持续性经营产生影响。免责声明：本文内容与数据由观点根据公开信息整理，不构成投资建议，使用前请核实。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/23231148332588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0188","BK1191","BK0177","BK1515","BK0183","BK0012","02196","BK0187","300452","BK0196","600196","BK0096","BK0028","BK0060","BK0175","BK1593"],"gpt_icon":0},{"id":"2513130758","title":"山河藥輔(300452.SZ)股東復星醫藥擬減持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2513130758","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513130758?lang=zh_tw&edition=fundamental","pubTime":"2025-02-23 22:00","pubTimestamp":1740319219,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山河药辅(300452.SZ)发布公告，持股10.20%的股东上海复星医药产业发展有限公司(以下简称“复星医药”)因经营需要，拟自公告发布之日起15个交易日后90日内(2025年3月18日至2025年6月15日)以集中竞价交易方式和大宗交易方式合计减持公司股份不超过697.8万股，即不超过公司总股本的3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0177","BK0239","BK1515","300452","BK0028","BK0060","BK1191","BK0187","600196","BK0096","02196","BK0012","BK0183","BK0188","BK1593","BK0175","BK0196"],"gpt_icon":0},{"id":"2513730339","title":"【山河藥輔：股東復星醫藥擬減持不超過3%公司股份】山河藥輔公告，股東上海復星醫藥產業發展有限公司因經營需要，計劃以集中競價和大宗交易方式合計減持公司股份不超過697.8萬股，即不超過公司總股本的3%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513730339","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513730339?lang=zh_tw&edition=fundamental","pubTime":"2025-02-23 21:10","pubTimestamp":1740316201,"startTime":"0","endTime":"0","summary":"山河药辅公告，股东上海复星医药产业发展有限公司因经营需要，计划以集中竞价和大宗交易方式合计减持公司股份不超过697.8万股，即不超过公司总股本的3%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/23211048332439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0096","BK0239","02196","BK0183","BK0012","BK0177","BK0188","BK1515","BK1593","BK0196","BK0028","BK0187","BK0060","300452","BK0175","BK1191","600196"],"gpt_icon":0},{"id":"2513735708","title":"【上海市工商聯生物醫藥商會揭牌，陳啓宇當選首任會長】2月22日，上海市工商聯生物醫藥商會第一屆一次會員會議暨生物醫藥發展大會在閔行區虹橋西郊莊園麗笙大酒店舉行。上海市工商聯生物醫藥商會正式揭牌，辦公落地閔行區，上海復星醫藥股份有限公司非執行董事陳啓宇當選首任會長。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513735708","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513735708?lang=zh_tw&edition=fundamental","pubTime":"2025-02-23 16:55","pubTimestamp":1740300954,"startTime":"0","endTime":"0","summary":"2月22日，上海市工商联生物医药商会第一届一次会员会议暨生物医药发展大会在闵行区虹桥西郊庄园丽笙大酒店举行。上海市工商联生物医药商会正式揭牌，办公落地闵行区，上海复星医药股份有限公司非执行董事陈启宇当选首任会长。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/23165548332126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1593","BK0239","399441","BK0060","BK0183","BK0012","BK1191","600196","02196","BK0096","BK0028","BK0187","BK0175","BK1164","00045","161726","BK0188","BK0196","BK1515"],"gpt_icon":0}],"pageSize":16,"totalPage":9,"pageCount":9,"totalSize":136}]}}